Global In Vitro Diagnostics Market Research Report
- Report Code: IN 1000
- Publish Date: Upcoming
The Global In Vitro Diagnostics Market is growing due to ongoing developments in analytical laboratory automation; the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries. The most important trend witnessed recently in the IVD industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital.
In the last five years, the global IVD industry has witnessed challenging and dynamic market conditions in terms of rising incidences of chronic diseases, increasing awareness of health and fitness, as well as major technological advancements. The overall IVD market was worth $49.2 billion in 2013 and is estimated to grow at an annual growth rate of 7% over the next five years. The market displays a growing preference for mergers and acquisitions to ensure the sustainability and growth of a company.
In 2013, the Americas had the largest market, a 42% share of the global IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.
The major changes in In Vitro Diagnostics have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The In Vitro Diagnostics market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems.
The report “Global In Vitro Diagnostics Market forecast for 2018” analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.
The Americas commanded the largest share in the global In Vitro Diagnostics market. Although, overall, Europe showed a negative growth rate, revenues grew compared to 2011 in some countries. Germany commanded the largest share in European IVD market.
Asian IVD market is growing in double digit and will continue to grow in future. China commanded the largest share in Asian IVD market.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in In Vitro Diagnostics Market and extensively covered in this report are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickson and Company (U.S.), Siemens Healthcare (Germany), Diagnostica Stago SAS (France), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Sysmex Corporation (Japan), bioMérieux (France), HORIBA, Ltd. (Japan), and Alere, Inc. (U.S.)
Segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep-dive analysis of the following parameters:
Opportunity Analysis
- Unmet needs, revenue pockets and potential areas for expansion
Supplier Evaluation
- Comprehensive review of key suppliers
Lab testing Data
- Number of IVD tests performed annually in each country tracked till sub-segment level
Current and Emerging Products
- Analysis of current and emerging In Vitro Diagnostics and immunodiagnostic tests
- Review of current In Vitro Diagnostics instrumentation technologies, and feature comparison of high, medium, and low-volume/POC analyzers
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user adoption rate analysis of the products (Segment and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool, checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Payment Link Hematology Market Study Payment Link Hematology Market Study |
Upcoming |
|
|
Coagulation The hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. The coagulation market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Clinical Chemistry The global clinical chemistry market was valued at $10.3 Billion in 2013 and is growing at a CAGR of 8.3%. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Immunoassay Global Immunoassay Market forecast is pegged at $12.5 Billion in 2013 and growing at a CAGR of 8.5%. Global Immunoassay Market can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Microbiology In 2013, the microbiology testing market was 5% to the Global IVD Market and contributed $3556.7 million in 2013 to the IVD market and is estimated to reach $4737.2 million by 2018, at a CAGR of 6.2% from 2013 to 2018. The report “Global Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents. |
Upcoming |
|
|
Molecular Diagnostics The report “Global Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. These two segments experienced a positive growth till 2013, with a market value of $4.95 Billion, Comprises of $4.17 Billion for reagents and $0.77 Billion for instruments and growing at a CAGR of 10.2%. |
Upcoming |
|
|
Instruments The IVD Instruments market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. The report “Global IVD Instruments Market forecast for 2018 “analyzes the market by 3 segments such as high risk and risk devices, devices for self testing and other devices. |
Upcoming |
|
|
Reagents & Kits The IVD Reagents & Kits market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new Reagents & Kits, calibrators, and other systems. The report “Global IVD Reagents & Kits Market forecast for 2018 “analyzes the market by 2 segments such as general purpose Reagents & Kits and analyte specific Reagents & Kits. |
Upcoming |
|
|
Services & Software Services & Software and Instruments and Reagents & Kits adds up to total... |
Upcoming |
|
|
Tissue Diagnostics The Global Tissue Diagnostics Devices Market, mainly driven by rapidly increasing incidence of cancer, was pegged at $1463.87 million in 2013 and expected to be $2069.02 million by 2018, growing at a CAGR of 7.1% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), In situ hybridization (ISH), Digital pathology, and Special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.). |
Upcoming |
|
|
Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. Germany commanded the largest share of the European enzyme immunoassays market. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market. The report “Global Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Fluorescence Immunoassays (FIA) Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. FIA gives the same sensitivity as radioimmunoassay (RIA) and enzyme immunoassays (EIA), but at lower costs because the fluorescent dyes are available at lower prices when compared to enzymes and radioisotopes. The report “Global Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Chemiluminescence Immunoassays (CLIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas Chemiluminescence immunoassays (CLIA) market, Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market, Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market. The report “Global Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Radioimmunoassays (RIA) Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “Global Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Mechanical Mechanical and Immunologic, Chemical (Chromogenic) Assays... |
Upcoming |
|
|
Immunologic Immunologic and Mechanical, Chemical (Chromogenic) Assays... |
Upcoming |
|
|
Chemical (Chromogenic) Assays Chemical (Chromogenic) Assays and Mechanical, Immunologic and |
Upcoming |
|
|
Molecular PCR Testing Molecular PCR Testing and Mechanical, Immunologic and |
Upcoming |
|
|
Immunohistochemistry Immunohistochemistry and Next Generation Sequencing (NGS) and |
Upcoming |
|
|
Blood Blood and Hematology Cell Counters, Hematology Analyzers, Immuno Hematology, Hematology Reagents, Hematology Services, Hematology Rapid Testing and Hemostasis adds up to total |
Upcoming |
